| Robert Marcus Jr, MD | |
|
1545 Airport Blvd, Suite 1000, Pensacola, FL 32504-8615 | |
| (850) 416-6770 | |
| (850) 416-7770 |
| Full Name | Robert Marcus Jr |
|---|---|
| Gender | Male |
| Speciality | Radiation Oncology |
| Experience | 49 Years |
| Location | 1545 Airport Blvd, Pensacola, Florida |
| Accepts Medicare Assignments | Yes. He accepts the Medicare-approved amount; you will not be billed for any more than the Medicare deductible and coinsurance. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1023024189 | NPI | - | NPPES |
| 000189400 | Medicaid | FL |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 2085R0001X | Radiology - Radiation Oncology | 029347 (Georgia) | Secondary |
| 2085R0203X | Radiology - Therapeutic Radiology | 29054 (Florida) | Primary |
| Group Practice Name | Group PECOS PAC ID | No. of Members |
|---|---|---|
| Poplar Bluff Hma Physician Management, Llc | 5092769703 | 37 |
News Archive
New UCLA-led research finds that Zika-linked abnormalities that occur in human fetuses are more extensive — and severe — than previously thought, with 46 percent of 125 pregnancies among Zika-infected women resulting in birth defects in newborns or ending in fetal death.
Neoprobe Corporation, a diversified developer of innovative oncology surgical and diagnostic products, announced today that it has submitted an investigational new drug (IND) amendment to the United States Food and Drug Administration (FDA) which includes the design of a proposed Phase 3 clinical trial of Neoprobe's RIGScan® CR radiopharmaceutical.
Obese rhesus monkeys lost on average 11 percent of their body weight after four weeks of treatment with an experimental drug that selectively destroys the blood supply of fat tissue, a research team led by scientists at The University of Texas MD Anderson Cancer Center reports in Science Translational Medicine.
Members of the House Ways and Means Committee and the Energy and Commerce Committee are following the spending trail of Obama administration health programs.
› Verified 7 days ago
| Entity Name | Kansas City Urology Care Pa |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1528024676 PECOS PAC ID: 9032006853 Enrollment ID: O20040304000362 |
News Archive
New UCLA-led research finds that Zika-linked abnormalities that occur in human fetuses are more extensive — and severe — than previously thought, with 46 percent of 125 pregnancies among Zika-infected women resulting in birth defects in newborns or ending in fetal death.
Neoprobe Corporation, a diversified developer of innovative oncology surgical and diagnostic products, announced today that it has submitted an investigational new drug (IND) amendment to the United States Food and Drug Administration (FDA) which includes the design of a proposed Phase 3 clinical trial of Neoprobe's RIGScan® CR radiopharmaceutical.
Obese rhesus monkeys lost on average 11 percent of their body weight after four weeks of treatment with an experimental drug that selectively destroys the blood supply of fat tissue, a research team led by scientists at The University of Texas MD Anderson Cancer Center reports in Science Translational Medicine.
Members of the House Ways and Means Committee and the Energy and Commerce Committee are following the spending trail of Obama administration health programs.
› Verified 7 days ago
| Entity Name | Poplar Bluff Hma Physician Management, Llc |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1598710147 PECOS PAC ID: 5092769703 Enrollment ID: O20050307000013 |
News Archive
New UCLA-led research finds that Zika-linked abnormalities that occur in human fetuses are more extensive — and severe — than previously thought, with 46 percent of 125 pregnancies among Zika-infected women resulting in birth defects in newborns or ending in fetal death.
Neoprobe Corporation, a diversified developer of innovative oncology surgical and diagnostic products, announced today that it has submitted an investigational new drug (IND) amendment to the United States Food and Drug Administration (FDA) which includes the design of a proposed Phase 3 clinical trial of Neoprobe's RIGScan® CR radiopharmaceutical.
Obese rhesus monkeys lost on average 11 percent of their body weight after four weeks of treatment with an experimental drug that selectively destroys the blood supply of fat tissue, a research team led by scientists at The University of Texas MD Anderson Cancer Center reports in Science Translational Medicine.
Members of the House Ways and Means Committee and the Energy and Commerce Committee are following the spending trail of Obama administration health programs.
› Verified 7 days ago
| Mailing Address | Practice Location Address |
|---|---|
| Robert Marcus Jr, MD Po Box 2699, Pensacola, FL 32513-2699 Ph: (850) 416-6770 | Robert Marcus Jr, MD 1545 Airport Blvd, Suite 1000, Pensacola, FL 32504-8615 Ph: (850) 416-6770 |
News Archive
New UCLA-led research finds that Zika-linked abnormalities that occur in human fetuses are more extensive — and severe — than previously thought, with 46 percent of 125 pregnancies among Zika-infected women resulting in birth defects in newborns or ending in fetal death.
Neoprobe Corporation, a diversified developer of innovative oncology surgical and diagnostic products, announced today that it has submitted an investigational new drug (IND) amendment to the United States Food and Drug Administration (FDA) which includes the design of a proposed Phase 3 clinical trial of Neoprobe's RIGScan® CR radiopharmaceutical.
Obese rhesus monkeys lost on average 11 percent of their body weight after four weeks of treatment with an experimental drug that selectively destroys the blood supply of fat tissue, a research team led by scientists at The University of Texas MD Anderson Cancer Center reports in Science Translational Medicine.
Members of the House Ways and Means Committee and the Energy and Commerce Committee are following the spending trail of Obama administration health programs.
› Verified 7 days ago
Dr. Christopher John Manganello, M.D. Radiology Medicare: Medicare Enrolled Practice Location: 6000 W Highway 98, Pensacola, FL 32512 Phone: 850-505-6601 | |
Dr. Steven J Sukstorf, MD Radiology Medicare: Medicare Enrolled Practice Location: 4511 N Davis Hwy, Ste 1b, Pensacola, FL 32503 Phone: 850-484-8454 | |
Robert M Smith Ii, MD Radiology Medicare: Accepting Medicare Assignments Practice Location: 1000 West Moreno Street, Pensacola, FL 32501 Phone: 850-436-4951 Fax: 850-438-6767 | |
Dr. Donald W Farmer, M.D. Radiology Medicare: Accepting Medicare Assignments Practice Location: 5151 N 9th Ave, Pensacola, FL 32504 Phone: 850-416-6020 | |
Dr. William R. Balchunas, M.D. Radiology Medicare: Not Enrolled in Medicare Practice Location: 5151 N 9th Ave, Pensacola, FL 32504 Phone: 850-416-6020 | |
Dr. Veronica A Carden, M.D. Radiology Medicare: Accepting Medicare Assignments Practice Location: 1545 Airport Blvd, Suite 1000, Pensacola, FL 32504 Phone: 850-416-6700 Fax: 850-416-7770 |